A Frameshift Mutation and Alternate Splicing in Human Brain Generate a Functional Form of the Pseudogene Cytochrome P4502D7 That Demethylates Codeine to Morphine*
暂无分享,去创建一个
[1] 刘金明,et al. IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .
[2] A. Hodgson,et al. Expression analysis of the mixed function oxidase system in rat brain by the polymerase chain reaction , 1993, Molecular and Cellular Biochemistry.
[3] E. Benoit,et al. Cloning, sequencing and tissue distribution of rat flavin-containing monooxygenase 4: two different forms are produced by tissue-specific alternative splicing. , 2003, Molecular pharmacology.
[4] Ulrich M. Zanger,et al. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.
[5] R. Howard,et al. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. , 2002, British journal of anaesthesia.
[6] M. Huestis,et al. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. , 2002, Clinical chemistry.
[7] M. Boyd,et al. Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain. , 2002, Brain research. Molecular brain research.
[8] V. Ravindranath,et al. Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite , 2002, The Pharmacogenomics Journal.
[9] D. Black,et al. Alternative RNA splicing in the nervous system , 2001, Progress in Neurobiology.
[10] J. Gustafsson,et al. Cytochrome P450 in the brain; a review. , 2001, Current drug metabolism.
[11] A. Molven,et al. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism? , 2001, Pharmacogenetics.
[12] H. Owen,et al. Variable Cytochrome P450 2D6 Expression and Metabolism of Codeine and Other Opioid Prodrugs: Implications for the Australian Anaesthetist , 2000, Anaesthesia and intensive care.
[13] E. E. Bagley,et al. Cellular Actions Of Opioids And Other Analgesics: Implications For Synergism In Pain Relief , 2000, Clinical and experimental pharmacology & physiology.
[14] C. Bouras,et al. Cytochrome P-450 activities in human and rat brain microsomes , 2000, Brain Research.
[15] M. Boyd,et al. Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. , 2000, Archives of biochemistry and biophysics.
[16] G. Murray,et al. Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. , 1998, Biochemical pharmacology.
[17] H. Strobel,et al. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. , 1997, Archives of biochemistry and biophysics.
[18] F. Guengerich,et al. Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[19] M. Boyd,et al. Further characterization of rat brain flavin-containing monooxygenase. Metabolism of imipramine to its N-oxide. , 1996, Biochemical pharmacology.
[20] S. Sindrup,et al. The pharmacogenetics of codeine hypoalgesia. , 1995, Pharmacogenetics.
[21] M. Boyd,et al. Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility. , 1995, Archives of biochemistry and biophysics.
[22] M. Boyd,et al. Xenobiotic metabolism in brain. , 1995, Drug metabolism reviews.
[23] J. Gustafsson,et al. Effect of ethanol on cytochrome P450 in the rat brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Gustafsson,et al. Regulation of cytochrome P450 in the central nervous system , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[25] M. Komori. A novel P450 expressed at the high level in rat brain. , 1993, Biochemical and biophysical research communications.
[26] L. Arendt-Nielsen,et al. Are poor metabolisers of sparteine/debrisoquine less pain tolerant than extensive metabolisers? , 1993, Pain.
[27] S. Sindrup,et al. Role of genetic polymorphism in psychopharmacology--an update. , 1993, Psychopharmacology series.
[28] M. Boyd,et al. Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain. , 1992, The Biochemical journal.
[29] S. Shankar,et al. Microsomal cytochrome P450 in human brain regions. , 1992, Biochemical pharmacology.
[30] F. Gonzalez,et al. Human cytochromes P450: problems and prospects. , 1992, Trends in pharmacological sciences.
[31] R. Tyndale,et al. Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase). , 1991, British journal of clinical pharmacology.
[32] S. Shankar,et al. Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms , 1990, Brain Research.
[33] M. Boyd,et al. Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines. , 1990, Journal of the National Cancer Institute.
[34] A. Somogyi,et al. Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia. , 1990, Life sciences.
[35] S. Shankar,et al. Xenobiotic metabolism in human brain — presence of cytochrome P-450 and associated mono-oxygenases , 1989, Brain Research.
[36] R. Skoda,et al. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. , 1989, American journal of human genetics.
[37] S. Spector,et al. Identification of the convulsant opiate thebaine in mammalian brain. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[38] Ortiz de Montellano,et al. Cytochrome P-450: Structure, Mechanism, and Biochemistry , 1986 .
[39] T. E. Gram,et al. The Metabolism of Xenobiotics by Certain Extrahepatic Organs and its Relation to Toxicity , 1986 .
[40] P. R. Montellano. Cytochrome P-450 , 1986, Springer US.
[41] M. R. Boyd,et al. Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. , 1980, Critical reviews in toxicology.
[42] G. H. Bush,et al. Pharmacogenetics , 1968 .